Concentra Group Holdings Parent, Inc. (NYSE: CON) Stock Competitors & Peer Comparison
See CON's competitors and their performance on the NYSE and across the wider stock market.
Peer Comparison Table: Medical - Care Facilities Industry
Detailed financial metrics including price, market cap, P/E ratio, and more for CON and its NYSE peers.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| CON | $35.43 | +0.88% | 4.5B | 24.59 | $1.44 | +0.71% |
| HCA | $404.68 | -1.71% | 87.6B | 13.97 | $28.96 | +0.74% |
| THC | $267.90 | +0.32% | 21.6B | 15.54 | $17.24 | N/A |
| FMS | $23.77 | +0.59% | 12.8B | 8.93 | $2.66 | +3.64% |
| EHC | $123.59 | +0.03% | 12.3B | 21.16 | $5.84 | +0.61% |
| BTSGU | $203.17 | +1.04% | 12B | 184.06 | $1.11 | N/A |
| DVA | $180.06 | -0.79% | 11.5B | 14.00 | $12.80 | N/A |
| ENSG | $181.65 | -0.13% | 10.6B | 26.33 | $6.90 | +0.14% |
| UHS | $170.02 | -0.70% | 10.3B | 7.54 | $22.54 | +0.47% |
| OSH | $39.00 | +0.08% | 9.5B | -17.65 | -$2.21 | N/A |
Stock Comparison
HCA Healthcare, Inc. (NYSE: HCA)
CON vs HCA Comparison August 2026
Concentra Group Holdings Parent, Inc. (NYSE: CON) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CON stands at 4.5B. In comparison, HCA has a market cap of 87.6B. Regarding current trading prices, CON is priced at $35.43 on the NYSE, while HCA trades at $404.68.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CON currently has a P/E ratio of 24.59, whereas HCA's P/E ratio is 13.97. In terms of profitability, CON's ROE is +0.47%, compared to HCA's ROE of -1.13%. Regarding short-term risk, CON is less volatile compared to HCA. This indicates lower risk in terms of short-term price fluctuations for CON.Check HCA's competition here
Tenet Healthcare Corporation (NYSE: THC)
CON vs THC Comparison August 2026
Concentra Group Holdings Parent, Inc. (NYSE: CON) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CON stands at 4.5B. In comparison, THC has a market cap of 21.6B. Regarding current trading prices, CON is priced at $35.43 on the NYSE, while THC trades at $267.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CON currently has a P/E ratio of 24.59, whereas THC's P/E ratio is 15.54. In terms of profitability, CON's ROE is +0.47%, compared to THC's ROE of +0.51%. Regarding short-term risk, CON is more volatile compared to THC. This indicates higher risk in terms of short-term price fluctuations for CON.Check THC's competition here
Fresenius Medical Care AG & Co. KGaA (NYSE: FMS)
CON vs FMS Comparison August 2026
Concentra Group Holdings Parent, Inc. (NYSE: CON) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CON stands at 4.5B. In comparison, FMS has a market cap of 12.8B. Regarding current trading prices, CON is priced at $35.43 on the NYSE, while FMS trades at $23.77.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CON currently has a P/E ratio of 24.59, whereas FMS's P/E ratio is 8.93. In terms of profitability, CON's ROE is +0.47%, compared to FMS's ROE of +0.07%. Regarding short-term risk, CON is more volatile compared to FMS. This indicates higher risk in terms of short-term price fluctuations for CON.Check FMS's competition here
Encompass Health Corporation (NYSE: EHC)
CON vs EHC Comparison August 2026
Concentra Group Holdings Parent, Inc. (NYSE: CON) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CON stands at 4.5B. In comparison, EHC has a market cap of 12.3B. Regarding current trading prices, CON is priced at $35.43 on the NYSE, while EHC trades at $123.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CON currently has a P/E ratio of 24.59, whereas EHC's P/E ratio is 21.16. In terms of profitability, CON's ROE is +0.47%, compared to EHC's ROE of +0.25%. Regarding short-term risk, CON is more volatile compared to EHC. This indicates higher risk in terms of short-term price fluctuations for CON.Check EHC's competition here
BrightSpring Health Services, Inc. Tangible Equity Unit (NASDAQ: BTSGU)
CON vs BTSGU Comparison August 2026
Concentra Group Holdings Parent, Inc. (NYSE: CON) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CON stands at 4.5B. In comparison, BTSGU has a market cap of 12B. Regarding current trading prices, CON is priced at $35.43 on the NYSE, while BTSGU trades at $203.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CON currently has a P/E ratio of 24.59, whereas BTSGU's P/E ratio is 184.06. In terms of profitability, CON's ROE is +0.47%, compared to BTSGU's ROE of +0.15%. Regarding short-term risk, CON is more volatile compared to BTSGU. This indicates higher risk in terms of short-term price fluctuations for CON.Check BTSGU's competition here
DaVita Inc. (NYSE: DVA)
CON vs DVA Comparison August 2026
Concentra Group Holdings Parent, Inc. (NYSE: CON) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CON stands at 4.5B. In comparison, DVA has a market cap of 11.5B. Regarding current trading prices, CON is priced at $35.43 on the NYSE, while DVA trades at $180.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CON currently has a P/E ratio of 24.59, whereas DVA's P/E ratio is 14.00. In terms of profitability, CON's ROE is +0.47%, compared to DVA's ROE of -1.24%. Regarding short-term risk, CON is less volatile compared to DVA. This indicates lower risk in terms of short-term price fluctuations for CON.Check DVA's competition here
The Ensign Group, Inc. (NASDAQ: ENSG)
CON vs ENSG Comparison August 2026
Concentra Group Holdings Parent, Inc. (NYSE: CON) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CON stands at 4.5B. In comparison, ENSG has a market cap of 10.6B. Regarding current trading prices, CON is priced at $35.43 on the NYSE, while ENSG trades at $181.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CON currently has a P/E ratio of 24.59, whereas ENSG's P/E ratio is 26.33. In terms of profitability, CON's ROE is +0.47%, compared to ENSG's ROE of +0.17%. Regarding short-term risk, CON is more volatile compared to ENSG. This indicates higher risk in terms of short-term price fluctuations for CON.Check ENSG's competition here
Universal Health Services, Inc. (NYSE: UHS)
CON vs UHS Comparison August 2026
Concentra Group Holdings Parent, Inc. (NYSE: CON) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CON stands at 4.5B. In comparison, UHS has a market cap of 10.3B. Regarding current trading prices, CON is priced at $35.43 on the NYSE, while UHS trades at $170.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CON currently has a P/E ratio of 24.59, whereas UHS's P/E ratio is 7.54. In terms of profitability, CON's ROE is +0.47%, compared to UHS's ROE of +0.21%. Regarding short-term risk, CON is more volatile compared to UHS. This indicates higher risk in terms of short-term price fluctuations for CON.Check UHS's competition here
Oak Street Health, Inc. (NYSE: OSH)
CON vs OSH Comparison August 2026
Concentra Group Holdings Parent, Inc. (NYSE: CON) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CON stands at 4.5B. In comparison, OSH has a market cap of 9.5B. Regarding current trading prices, CON is priced at $35.43 on the NYSE, while OSH trades at $39.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CON currently has a P/E ratio of 24.59, whereas OSH's P/E ratio is -17.65. In terms of profitability, CON's ROE is +0.47%, compared to OSH's ROE of +4.64%. Regarding short-term risk, CON is more volatile compared to OSH. This indicates higher risk in terms of short-term price fluctuations for CON.Check OSH's competition here
PACS Group, Inc. (NYSE: PACS)
CON vs PACS Comparison August 2026
Concentra Group Holdings Parent, Inc. (NYSE: CON) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CON stands at 4.5B. In comparison, PACS has a market cap of 7B. Regarding current trading prices, CON is priced at $35.43 on the NYSE, while PACS trades at $44.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CON currently has a P/E ratio of 24.59, whereas PACS's P/E ratio is 23.51. In terms of profitability, CON's ROE is +0.47%, compared to PACS's ROE of +0.27%. Regarding short-term risk, CON is less volatile compared to PACS. This indicates lower risk in terms of short-term price fluctuations for CON.Check PACS's competition here
Chemed Corporation (NYSE: CHE)
CON vs CHE Comparison August 2026
Concentra Group Holdings Parent, Inc. (NYSE: CON) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CON stands at 4.5B. In comparison, CHE has a market cap of 7B. Regarding current trading prices, CON is priced at $35.43 on the NYSE, while CHE trades at $532.88.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CON currently has a P/E ratio of 24.59, whereas CHE's P/E ratio is 24.67. In terms of profitability, CON's ROE is +0.47%, compared to CHE's ROE of +0.29%. Regarding short-term risk, CON is less volatile compared to CHE. This indicates lower risk in terms of short-term price fluctuations for CON.Check CHE's competition here
LHC Group, Inc. (NASDAQ: LHCG)
CON vs LHCG Comparison August 2026
Concentra Group Holdings Parent, Inc. (NYSE: CON) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CON stands at 4.5B. In comparison, LHCG has a market cap of 5.3B. Regarding current trading prices, CON is priced at $35.43 on the NYSE, while LHCG trades at $169.81.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CON currently has a P/E ratio of 24.59, whereas LHCG's P/E ratio is 82.83. In terms of profitability, CON's ROE is +0.47%, compared to LHCG's ROE of +0.04%. Regarding short-term risk, CON is more volatile compared to LHCG. This indicates higher risk in terms of short-term price fluctuations for CON.Check LHCG's competition here
LifeStance Health Group, Inc. (NASDAQ: LFST)
CON vs LFST Comparison August 2026
Concentra Group Holdings Parent, Inc. (NYSE: CON) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CON stands at 4.5B. In comparison, LFST has a market cap of 4.8B. Regarding current trading prices, CON is priced at $35.43 on the NYSE, while LFST trades at $12.42.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CON currently has a P/E ratio of 24.59, whereas LFST's P/E ratio is 93.55. In terms of profitability, CON's ROE is +0.47%, compared to LFST's ROE of +0.03%. Regarding short-term risk, CON is less volatile compared to LFST. This indicates lower risk in terms of short-term price fluctuations for CON.Check LFST's competition here
Option Care Health, Inc. (NASDAQ: OPCH)
CON vs OPCH Comparison August 2026
Concentra Group Holdings Parent, Inc. (NYSE: CON) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CON stands at 4.5B. In comparison, OPCH has a market cap of 3.6B. Regarding current trading prices, CON is priced at $35.43 on the NYSE, while OPCH trades at $23.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CON currently has a P/E ratio of 24.59, whereas OPCH's P/E ratio is 13.92. In terms of profitability, CON's ROE is +0.47%, compared to OPCH's ROE of +0.16%. Regarding short-term risk, CON is more volatile compared to OPCH. This indicates higher risk in terms of short-term price fluctuations for CON.Check OPCH's competition here
National HealthCare Corporation (AMEX: NHC)
CON vs NHC Comparison August 2026
Concentra Group Holdings Parent, Inc. (NYSE: CON) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CON stands at 4.5B. In comparison, NHC has a market cap of 3.5B. Regarding current trading prices, CON is priced at $35.43 on the NYSE, while NHC trades at $223.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CON currently has a P/E ratio of 24.59, whereas NHC's P/E ratio is 28.34. In terms of profitability, CON's ROE is +0.47%, compared to NHC's ROE of +0.13%. Regarding short-term risk, CON is less volatile compared to NHC. This indicates lower risk in terms of short-term price fluctuations for CON.Check NHC's competition here
Amedisys, Inc. (NASDAQ: AMED)
CON vs AMED Comparison August 2026
Concentra Group Holdings Parent, Inc. (NYSE: CON) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CON stands at 4.5B. In comparison, AMED has a market cap of 3.3B. Regarding current trading prices, CON is priced at $35.43 on the NYSE, while AMED trades at $100.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CON currently has a P/E ratio of 24.59, whereas AMED's P/E ratio is 39.30. In terms of profitability, CON's ROE is +0.47%, compared to AMED's ROE of +0.11%. Regarding short-term risk, CON is more volatile compared to AMED. This indicates higher risk in terms of short-term price fluctuations for CON.Check AMED's competition here
Brookdale Senior Living Inc. (NYSE: BKD)
CON vs BKD Comparison August 2026
Concentra Group Holdings Parent, Inc. (NYSE: CON) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CON stands at 4.5B. In comparison, BKD has a market cap of 3B. Regarding current trading prices, CON is priced at $35.43 on the NYSE, while BKD trades at $12.64.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CON currently has a P/E ratio of 24.59, whereas BKD's P/E ratio is -21.77. In terms of profitability, CON's ROE is +0.47%, compared to BKD's ROE of +4.06%. Regarding short-term risk, CON is less volatile compared to BKD. This indicates lower risk in terms of short-term price fluctuations for CON.Check BKD's competition here
Acadia Healthcare Company, Inc. (NASDAQ: ACHC)
CON vs ACHC Comparison August 2026
Concentra Group Holdings Parent, Inc. (NYSE: CON) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CON stands at 4.5B. In comparison, ACHC has a market cap of 2.9B. Regarding current trading prices, CON is priced at $35.43 on the NYSE, while ACHC trades at $30.83.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CON currently has a P/E ratio of 24.59, whereas ACHC's P/E ratio is 15.49. In terms of profitability, CON's ROE is +0.47%, compared to ACHC's ROE of -0.50%. Regarding short-term risk, CON is less volatile compared to ACHC. This indicates lower risk in terms of short-term price fluctuations for CON.Check ACHC's competition here
Aveanna Healthcare Holdings Inc. (NASDAQ: AVAH)
CON vs AVAH Comparison August 2026
Concentra Group Holdings Parent, Inc. (NYSE: CON) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CON stands at 4.5B. In comparison, AVAH has a market cap of 2.7B. Regarding current trading prices, CON is priced at $35.43 on the NYSE, while AVAH trades at $12.32.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CON currently has a P/E ratio of 24.59, whereas AVAH's P/E ratio is 18.12. In terms of profitability, CON's ROE is +0.47%, compared to AVAH's ROE of +1.50%. Regarding short-term risk, CON is less volatile compared to AVAH. This indicates lower risk in terms of short-term price fluctuations for CON.Check AVAH's competition here
Guardian Pharmacy Services, Inc. (NYSE: GRDN)
CON vs GRDN Comparison August 2026
Concentra Group Holdings Parent, Inc. (NYSE: CON) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CON stands at 4.5B. In comparison, GRDN has a market cap of 2.4B. Regarding current trading prices, CON is priced at $35.43 on the NYSE, while GRDN trades at $38.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CON currently has a P/E ratio of 24.59, whereas GRDN's P/E ratio is 33.72. In terms of profitability, CON's ROE is +0.47%, compared to GRDN's ROE of +0.31%. Regarding short-term risk, CON is less volatile compared to GRDN. This indicates lower risk in terms of short-term price fluctuations for CON.Check GRDN's competition here
Pediatrix Medical Group, Inc. (NYSE: MD)
CON vs MD Comparison August 2026
Concentra Group Holdings Parent, Inc. (NYSE: CON) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CON stands at 4.5B. In comparison, MD has a market cap of 2.2B. Regarding current trading prices, CON is priced at $35.43 on the NYSE, while MD trades at $26.61.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CON currently has a P/E ratio of 24.59, whereas MD's P/E ratio is 11.88. In terms of profitability, CON's ROE is +0.47%, compared to MD's ROE of +0.20%. Regarding short-term risk, CON is less volatile compared to MD. This indicates lower risk in terms of short-term price fluctuations for CON.Check MD's competition here
Addus HomeCare Corporation (NASDAQ: ADUS)
CON vs ADUS Comparison August 2026
Concentra Group Holdings Parent, Inc. (NYSE: CON) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CON stands at 4.5B. In comparison, ADUS has a market cap of 2.2B. Regarding current trading prices, CON is priced at $35.43 on the NYSE, while ADUS trades at $116.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CON currently has a P/E ratio of 24.59, whereas ADUS's P/E ratio is 17.37. In terms of profitability, CON's ROE is +0.47%, compared to ADUS's ROE of +0.10%. Regarding short-term risk, CON is more volatile compared to ADUS. This indicates higher risk in terms of short-term price fluctuations for CON.Check ADUS's competition here
Select Medical Holdings Corporation (NYSE: SEM)
CON vs SEM Comparison August 2026
Concentra Group Holdings Parent, Inc. (NYSE: CON) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CON stands at 4.5B. In comparison, SEM has a market cap of 2B. Regarding current trading prices, CON is priced at $35.43 on the NYSE, while SEM trades at $16.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CON currently has a P/E ratio of 24.59, whereas SEM's P/E ratio is 15.43. In terms of profitability, CON's ROE is +0.47%, compared to SEM's ROE of +0.08%. Regarding short-term risk, CON is more volatile compared to SEM. This indicates higher risk in terms of short-term price fluctuations for CON.Check SEM's competition here
Astrana Health, Inc. (NASDAQ: ASTH)
CON vs ASTH Comparison August 2026
Concentra Group Holdings Parent, Inc. (NYSE: CON) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CON stands at 4.5B. In comparison, ASTH has a market cap of 2B. Regarding current trading prices, CON is priced at $35.43 on the NYSE, while ASTH trades at $40.81.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CON currently has a P/E ratio of 24.59, whereas ASTH's P/E ratio is 39.24. In terms of profitability, CON's ROE is +0.47%, compared to ASTH's ROE of +0.05%. Regarding short-term risk, CON is less volatile compared to ASTH. This indicates lower risk in terms of short-term price fluctuations for CON.Check ASTH's competition here
Surgery Partners, Inc. (NASDAQ: SGRY)
CON vs SGRY Comparison August 2026
Concentra Group Holdings Parent, Inc. (NYSE: CON) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CON stands at 4.5B. In comparison, SGRY has a market cap of 2B. Regarding current trading prices, CON is priced at $35.43 on the NYSE, while SGRY trades at $15.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CON currently has a P/E ratio of 24.59, whereas SGRY's P/E ratio is 38.54. In terms of profitability, CON's ROE is +0.47%, compared to SGRY's ROE of -0.05%. Regarding short-term risk, CON is less volatile compared to SGRY. This indicates lower risk in terms of short-term price fluctuations for CON.Check SGRY's competition here
Sonida Senior Living, Inc. (NYSE: SNDA)
CON vs SNDA Comparison August 2026
Concentra Group Holdings Parent, Inc. (NYSE: CON) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CON stands at 4.5B. In comparison, SNDA has a market cap of 1.9B. Regarding current trading prices, CON is priced at $35.43 on the NYSE, while SNDA trades at $39.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CON currently has a P/E ratio of 24.59, whereas SNDA's P/E ratio is -7.25. In terms of profitability, CON's ROE is +0.47%, compared to SNDA's ROE of -0.26%. Regarding short-term risk, CON is less volatile compared to SNDA. This indicates lower risk in terms of short-term price fluctuations for CON.Check SNDA's competition here
Apollo Medical Holdings, Inc. (NASDAQ: AMEH)
CON vs AMEH Comparison August 2026
Concentra Group Holdings Parent, Inc. (NYSE: CON) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CON stands at 4.5B. In comparison, AMEH has a market cap of 1.8B. Regarding current trading prices, CON is priced at $35.43 on the NYSE, while AMEH trades at $40.82.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CON currently has a P/E ratio of 24.59, whereas AMEH's P/E ratio is 39.25. In terms of profitability, CON's ROE is +0.47%, compared to AMEH's ROE of +0.05%. Regarding short-term risk, CON is less volatile compared to AMEH. This indicates lower risk in terms of short-term price fluctuations for CON.Check AMEH's competition here
Agilon Health, Inc. (NYSE: AGL)
CON vs AGL Comparison August 2026
Concentra Group Holdings Parent, Inc. (NYSE: CON) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CON stands at 4.5B. In comparison, AGL has a market cap of 1.6B. Regarding current trading prices, CON is priced at $35.43 on the NYSE, while AGL trades at $96.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CON currently has a P/E ratio of 24.59, whereas AGL's P/E ratio is -10.83. In terms of profitability, CON's ROE is +0.47%, compared to AGL's ROE of -1.19%. Regarding short-term risk, CON is less volatile compared to AGL. This indicates lower risk in terms of short-term price fluctuations for CON.Check AGL's competition here
Ardent Health Inc. (NYSE: ARDT)
CON vs ARDT Comparison August 2026
Concentra Group Holdings Parent, Inc. (NYSE: CON) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CON stands at 4.5B. In comparison, ARDT has a market cap of 1.6B. Regarding current trading prices, CON is priced at $35.43 on the NYSE, while ARDT trades at $10.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CON currently has a P/E ratio of 24.59, whereas ARDT's P/E ratio is 8.81. In terms of profitability, CON's ROE is +0.47%, compared to ARDT's ROE of +0.05%. Regarding short-term risk, CON is less volatile compared to ARDT. This indicates lower risk in terms of short-term price fluctuations for CON.Check ARDT's competition here
Healthcare Services Group, Inc. (NASDAQ: HCSG)
CON vs HCSG Comparison August 2026
Concentra Group Holdings Parent, Inc. (NYSE: CON) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CON stands at 4.5B. In comparison, HCSG has a market cap of 1.5B. Regarding current trading prices, CON is priced at $35.43 on the NYSE, while HCSG trades at $21.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CON currently has a P/E ratio of 24.59, whereas HCSG's P/E ratio is 17.27. In terms of profitability, CON's ROE is +0.47%, compared to HCSG's ROE of +0.24%. Regarding short-term risk, CON is less volatile compared to HCSG. This indicates lower risk in terms of short-term price fluctuations for CON.Check HCSG's competition here
Innovage Holding Corp. (NASDAQ: INNV)
CON vs INNV Comparison August 2026
Concentra Group Holdings Parent, Inc. (NYSE: CON) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CON stands at 4.5B. In comparison, INNV has a market cap of 1.4B. Regarding current trading prices, CON is priced at $35.43 on the NYSE, while INNV trades at $10.61.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CON currently has a P/E ratio of 24.59, whereas INNV's P/E ratio is -117.89. In terms of profitability, CON's ROE is +0.47%, compared to INNV's ROE of -0.09%. Regarding short-term risk, CON is less volatile compared to INNV. This indicates lower risk in terms of short-term price fluctuations for CON.Check INNV's competition here
The Pennant Group, Inc. (NASDAQ: PNTG)
CON vs PNTG Comparison August 2026
Concentra Group Holdings Parent, Inc. (NYSE: CON) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CON stands at 4.5B. In comparison, PNTG has a market cap of 1.4B. Regarding current trading prices, CON is priced at $35.43 on the NYSE, while PNTG trades at $39.32.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CON currently has a P/E ratio of 24.59, whereas PNTG's P/E ratio is 29.79. In terms of profitability, CON's ROE is +0.47%, compared to PNTG's ROE of +0.10%. Regarding short-term risk, CON is less volatile compared to PNTG. This indicates lower risk in terms of short-term price fluctuations for CON.Check PNTG's competition here
AMN Healthcare Services, Inc. (NYSE: AMN)
CON vs AMN Comparison August 2026
Concentra Group Holdings Parent, Inc. (NYSE: CON) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CON stands at 4.5B. In comparison, AMN has a market cap of 1.3B. Regarding current trading prices, CON is priced at $35.43 on the NYSE, while AMN trades at $34.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CON currently has a P/E ratio of 24.59, whereas AMN's P/E ratio is 11.44. In terms of profitability, CON's ROE is +0.47%, compared to AMN's ROE of +0.15%. Regarding short-term risk, CON is less volatile compared to AMN. This indicates lower risk in terms of short-term price fluctuations for CON.Check AMN's competition here
Nutex Health, Inc. (NASDAQ: NUTX)
CON vs NUTX Comparison August 2026
Concentra Group Holdings Parent, Inc. (NYSE: CON) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CON stands at 4.5B. In comparison, NUTX has a market cap of 1.3B. Regarding current trading prices, CON is priced at $35.43 on the NYSE, while NUTX trades at $187.42.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CON currently has a P/E ratio of 24.59, whereas NUTX's P/E ratio is 14.48. In terms of profitability, CON's ROE is +0.47%, compared to NUTX's ROE of +0.52%. Regarding short-term risk, CON is less volatile compared to NUTX. This indicates lower risk in terms of short-term price fluctuations for CON.Check NUTX's competition here
U.S. Physical Therapy, Inc. (NYSE: USPH)
CON vs USPH Comparison August 2026
Concentra Group Holdings Parent, Inc. (NYSE: CON) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CON stands at 4.5B. In comparison, USPH has a market cap of 1.2B. Regarding current trading prices, CON is priced at $35.43 on the NYSE, while USPH trades at $81.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CON currently has a P/E ratio of 24.59, whereas USPH's P/E ratio is 31.94. In terms of profitability, CON's ROE is +0.47%, compared to USPH's ROE of +0.00%. Regarding short-term risk, CON is less volatile compared to USPH. This indicates lower risk in terms of short-term price fluctuations for CON.Check USPH's competition here
Brookdale Senior Living Inc. 7. (NYSE: BKDT)
CON vs BKDT Comparison August 2026
Concentra Group Holdings Parent, Inc. (NYSE: CON) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CON stands at 4.5B. In comparison, BKDT has a market cap of 1.2B. Regarding current trading prices, CON is priced at $35.43 on the NYSE, while BKDT trades at $77.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CON currently has a P/E ratio of 24.59, whereas BKDT's P/E ratio is N/A. In terms of profitability, CON's ROE is +0.47%, compared to BKDT's ROE of +4.06%. Regarding short-term risk, CON is more volatile compared to BKDT. This indicates higher risk in terms of short-term price fluctuations for CON.Check BKDT's competition here
Talkspace, Inc. (NASDAQ: TALK)
CON vs TALK Comparison August 2026
Concentra Group Holdings Parent, Inc. (NYSE: CON) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CON stands at 4.5B. In comparison, TALK has a market cap of 879.4M. Regarding current trading prices, CON is priced at $35.43 on the NYSE, while TALK trades at $5.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CON currently has a P/E ratio of 24.59, whereas TALK's P/E ratio is 774.34. In terms of profitability, CON's ROE is +0.47%, compared to TALK's ROE of +0.00%. Regarding short-term risk, CON is more volatile compared to TALK. This indicates higher risk in terms of short-term price fluctuations for CON.Check TALK's competition here
Fidelity Select Health Care Svcs Port (NASDAQ: FSHCX)
CON vs FSHCX Comparison August 2026
Concentra Group Holdings Parent, Inc. (NYSE: CON) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CON stands at 4.5B. In comparison, FSHCX has a market cap of 877.3M. Regarding current trading prices, CON is priced at $35.43 on the NYSE, while FSHCX trades at $116.81.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CON currently has a P/E ratio of 24.59, whereas FSHCX's P/E ratio is N/A. In terms of profitability, CON's ROE is +0.47%, compared to FSHCX's ROE of N/A. Regarding short-term risk, CON is more volatile compared to FSHCX. This indicates higher risk in terms of short-term price fluctuations for CON.Check FSHCX's competition here
GMR Solutions Inc. (NYSE: GMRS)
CON vs GMRS Comparison August 2026
Concentra Group Holdings Parent, Inc. (NYSE: CON) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CON stands at 4.5B. In comparison, GMRS has a market cap of 718.9M. Regarding current trading prices, CON is priced at $35.43 on the NYSE, while GMRS trades at $13.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CON currently has a P/E ratio of 24.59, whereas GMRS's P/E ratio is 5.92. In terms of profitability, CON's ROE is +0.47%, compared to GMRS's ROE of +0.16%. Regarding short-term risk, CON is less volatile compared to GMRS. This indicates lower risk in terms of short-term price fluctuations for CON.Check GMRS's competition here
Enhabit, Inc. (NYSE: EHAB)
CON vs EHAB Comparison August 2026
Concentra Group Holdings Parent, Inc. (NYSE: CON) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CON stands at 4.5B. In comparison, EHAB has a market cap of 706.9M. Regarding current trading prices, CON is priced at $35.43 on the NYSE, while EHAB trades at $13.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CON currently has a P/E ratio of 24.59, whereas EHAB's P/E ratio is -197.14. In terms of profitability, CON's ROE is +0.47%, compared to EHAB's ROE of -0.01%. Regarding short-term risk, CON is more volatile compared to EHAB. This indicates higher risk in terms of short-term price fluctuations for CON.Check EHAB's competition here
Starling Oncology, Inc. (NASDAQ: STLN)
CON vs STLN Comparison August 2026
Concentra Group Holdings Parent, Inc. (NYSE: CON) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CON stands at 4.5B. In comparison, STLN has a market cap of 644.9M. Regarding current trading prices, CON is priced at $35.43 on the NYSE, while STLN trades at $6.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CON currently has a P/E ratio of 24.59, whereas STLN's P/E ratio is N/A. In terms of profitability, CON's ROE is +0.47%, compared to STLN's ROE of +2.10%. Regarding short-term risk, CON is less volatile compared to STLN. This indicates lower risk in terms of short-term price fluctuations for CON.Check STLN's competition here
The Oncology Institute, Inc. (NASDAQ: TOI)
CON vs TOI Comparison August 2026
Concentra Group Holdings Parent, Inc. (NYSE: CON) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CON stands at 4.5B. In comparison, TOI has a market cap of 512.9M. Regarding current trading prices, CON is priced at $35.43 on the NYSE, while TOI trades at $5.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CON currently has a P/E ratio of 24.59, whereas TOI's P/E ratio is -14.25. In terms of profitability, CON's ROE is +0.47%, compared to TOI's ROE of +2.10%. Regarding short-term risk, CON is less volatile compared to TOI. This indicates lower risk in terms of short-term price fluctuations for CON.Check TOI's competition here
Strata Critical Medical, Inc. (NASDAQ: SRTA)
CON vs SRTA Comparison August 2026
Concentra Group Holdings Parent, Inc. (NYSE: CON) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CON stands at 4.5B. In comparison, SRTA has a market cap of 510.5M. Regarding current trading prices, CON is priced at $35.43 on the NYSE, while SRTA trades at $5.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CON currently has a P/E ratio of 24.59, whereas SRTA's P/E ratio is -27.81. In terms of profitability, CON's ROE is +0.47%, compared to SRTA's ROE of +0.14%. Regarding short-term risk, CON is less volatile compared to SRTA. This indicates lower risk in terms of short-term price fluctuations for CON.Check SRTA's competition here
Charming Medical Limited Class A Ordinary Shares (NASDAQ: MCTA)
CON vs MCTA Comparison August 2026
Concentra Group Holdings Parent, Inc. (NYSE: CON) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CON stands at 4.5B. In comparison, MCTA has a market cap of 445.6M. Regarding current trading prices, CON is priced at $35.43 on the NYSE, while MCTA trades at $29.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CON currently has a P/E ratio of 24.59, whereas MCTA's P/E ratio is 419.36. In terms of profitability, CON's ROE is +0.47%, compared to MCTA's ROE of -2.33%. Regarding short-term risk, CON is more volatile compared to MCTA. This indicates higher risk in terms of short-term price fluctuations for CON.Check MCTA's competition here
Community Health Systems, Inc. (NYSE: CYH)
CON vs CYH Comparison August 2026
Concentra Group Holdings Parent, Inc. (NYSE: CON) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CON stands at 4.5B. In comparison, CYH has a market cap of 419.5M. Regarding current trading prices, CON is priced at $35.43 on the NYSE, while CYH trades at $3.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CON currently has a P/E ratio of 24.59, whereas CYH's P/E ratio is 4.08. In terms of profitability, CON's ROE is +0.47%, compared to CYH's ROE of +0.21%. Regarding short-term risk, CON is less volatile compared to CYH. This indicates lower risk in terms of short-term price fluctuations for CON.Check CYH's competition here
Auna S.A. (NYSE: AUNA)
CON vs AUNA Comparison August 2026
Concentra Group Holdings Parent, Inc. (NYSE: CON) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CON stands at 4.5B. In comparison, AUNA has a market cap of 388.6M. Regarding current trading prices, CON is priced at $35.43 on the NYSE, while AUNA trades at $5.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CON currently has a P/E ratio of 24.59, whereas AUNA's P/E ratio is 4.73. In terms of profitability, CON's ROE is +0.47%, compared to AUNA's ROE of +0.04%. Regarding short-term risk, CON is less volatile compared to AUNA. This indicates lower risk in terms of short-term price fluctuations for CON.Check AUNA's competition here
Viemed Healthcare, Inc. (NASDAQ: VMD)
CON vs VMD Comparison August 2026
Concentra Group Holdings Parent, Inc. (NYSE: CON) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CON stands at 4.5B. In comparison, VMD has a market cap of 350.4M. Regarding current trading prices, CON is priced at $35.43 on the NYSE, while VMD trades at $9.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CON currently has a P/E ratio of 24.59, whereas VMD's P/E ratio is 25.56. In terms of profitability, CON's ROE is +0.47%, compared to VMD's ROE of +0.10%. Regarding short-term risk, CON is less volatile compared to VMD. This indicates lower risk in terms of short-term price fluctuations for CON.Check VMD's competition here
AirSculpt Technologies, Inc. (NASDAQ: AIRS)
CON vs AIRS Comparison August 2026
Concentra Group Holdings Parent, Inc. (NYSE: CON) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CON stands at 4.5B. In comparison, AIRS has a market cap of 242M. Regarding current trading prices, CON is priced at $35.43 on the NYSE, while AIRS trades at $3.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CON currently has a P/E ratio of 24.59, whereas AIRS's P/E ratio is -114.33. In terms of profitability, CON's ROE is +0.47%, compared to AIRS's ROE of -0.13%. Regarding short-term risk, CON is less volatile compared to AIRS. This indicates lower risk in terms of short-term price fluctuations for CON.Check AIRS's competition here
Capital Senior Living Corporation (NYSE: CSU)
CON vs CSU Comparison August 2026
Concentra Group Holdings Parent, Inc. (NYSE: CON) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CON stands at 4.5B. In comparison, CSU has a market cap of 223.7M. Regarding current trading prices, CON is priced at $35.43 on the NYSE, while CSU trades at $33.54.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CON currently has a P/E ratio of 24.59, whereas CSU's P/E ratio is 0.67. In terms of profitability, CON's ROE is +0.47%, compared to CSU's ROE of -0.33%. Regarding short-term risk, CON is less volatile compared to CSU. This indicates lower risk in terms of short-term price fluctuations for CON.Check CSU's competition here
The Joint Corp. (NASDAQ: JYNT)
CON vs JYNT Comparison August 2026
Concentra Group Holdings Parent, Inc. (NYSE: CON) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CON stands at 4.5B. In comparison, JYNT has a market cap of 120.5M. Regarding current trading prices, CON is priced at $35.43 on the NYSE, while JYNT trades at $8.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CON currently has a P/E ratio of 24.59, whereas JYNT's P/E ratio is 84.50. In terms of profitability, CON's ROE is +0.47%, compared to JYNT's ROE of +0.22%. Regarding short-term risk, CON is less volatile compared to JYNT. This indicates lower risk in terms of short-term price fluctuations for CON.Check JYNT's competition here
Park Dental Partners, Inc. Common Stock (NASDAQ: PARK)
CON vs PARK Comparison August 2026
Concentra Group Holdings Parent, Inc. (NYSE: CON) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CON stands at 4.5B. In comparison, PARK has a market cap of 103.9M. Regarding current trading prices, CON is priced at $35.43 on the NYSE, while PARK trades at $22.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CON currently has a P/E ratio of 24.59, whereas PARK's P/E ratio is 31.11. In terms of profitability, CON's ROE is +0.47%, compared to PARK's ROE of -0.00%. Regarding short-term risk, CON is less volatile compared to PARK. This indicates lower risk in terms of short-term price fluctuations for CON.Check PARK's competition here
Five Star Senior Living Inc. (NASDAQ: FVE)
CON vs FVE Comparison August 2026
Concentra Group Holdings Parent, Inc. (NYSE: CON) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CON stands at 4.5B. In comparison, FVE has a market cap of 98.4M. Regarding current trading prices, CON is priced at $35.43 on the NYSE, while FVE trades at $2.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CON currently has a P/E ratio of 24.59, whereas FVE's P/E ratio is -5.64. In terms of profitability, CON's ROE is +0.47%, compared to FVE's ROE of -0.15%. Regarding short-term risk, CON is less volatile compared to FVE. This indicates lower risk in terms of short-term price fluctuations for CON.Check FVE's competition here
Kindly MD, Inc. (NASDAQ: KDLYW)
CON vs KDLYW Comparison August 2026
Concentra Group Holdings Parent, Inc. (NYSE: CON) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CON stands at 4.5B. In comparison, KDLYW has a market cap of 96.5M. Regarding current trading prices, CON is priced at $35.43 on the NYSE, while KDLYW trades at $18.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CON currently has a P/E ratio of 24.59, whereas KDLYW's P/E ratio is N/A. In terms of profitability, CON's ROE is +0.47%, compared to KDLYW's ROE of -1.05%. Regarding short-term risk, CON is less volatile compared to KDLYW. This indicates lower risk in terms of short-term price fluctuations for CON.Check KDLYW's competition here
biote Corp. (NASDAQ: BTMD)
CON vs BTMD Comparison August 2026
Concentra Group Holdings Parent, Inc. (NYSE: CON) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CON stands at 4.5B. In comparison, BTMD has a market cap of 64.8M. Regarding current trading prices, CON is priced at $35.43 on the NYSE, while BTMD trades at $1.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CON currently has a P/E ratio of 24.59, whereas BTMD's P/E ratio is 13.36. In terms of profitability, CON's ROE is +0.47%, compared to BTMD's ROE of -0.09%. Regarding short-term risk, CON is less volatile compared to BTMD. This indicates lower risk in terms of short-term price fluctuations for CON.Check BTMD's competition here
DocGo Inc. (NASDAQ: DCGO)
CON vs DCGO Comparison August 2026
Concentra Group Holdings Parent, Inc. (NYSE: CON) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CON stands at 4.5B. In comparison, DCGO has a market cap of 64.5M. Regarding current trading prices, CON is priced at $35.43 on the NYSE, while DCGO trades at $0.67.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CON currently has a P/E ratio of 24.59, whereas DCGO's P/E ratio is -0.75. In terms of profitability, CON's ROE is +0.47%, compared to DCGO's ROE of -0.89%. Regarding short-term risk, CON is less volatile compared to DCGO. This indicates lower risk in terms of short-term price fluctuations for CON.Check DCGO's competition here
AlerisLife Inc. (NASDAQ: ALR)
CON vs ALR Comparison August 2026
Concentra Group Holdings Parent, Inc. (NYSE: CON) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CON stands at 4.5B. In comparison, ALR has a market cap of 44.2M. Regarding current trading prices, CON is priced at $35.43 on the NYSE, while ALR trades at $1.32.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CON currently has a P/E ratio of 24.59, whereas ALR's P/E ratio is -1.11. In terms of profitability, CON's ROE is +0.47%, compared to ALR's ROE of -0.15%. Regarding short-term risk, CON is more volatile compared to ALR. This indicates higher risk in terms of short-term price fluctuations for CON.Check ALR's competition here
P3 Health Partners Inc. (NASDAQ: PIII)
CON vs PIII Comparison August 2026
Concentra Group Holdings Parent, Inc. (NYSE: CON) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CON stands at 4.5B. In comparison, PIII has a market cap of 35M. Regarding current trading prices, CON is priced at $35.43 on the NYSE, while PIII trades at $10.69.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CON currently has a P/E ratio of 24.59, whereas PIII's P/E ratio is -0.27. In terms of profitability, CON's ROE is +0.47%, compared to PIII's ROE of +1.61%. Regarding short-term risk, CON is less volatile compared to PIII. This indicates lower risk in terms of short-term price fluctuations for CON.Check PIII's competition here
IMAC Holdings, Inc. (NASDAQ: IMAC)
CON vs IMAC Comparison August 2026
Concentra Group Holdings Parent, Inc. (NYSE: CON) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CON stands at 4.5B. In comparison, IMAC has a market cap of 33.1M. Regarding current trading prices, CON is priced at $35.43 on the NYSE, while IMAC trades at $1.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CON currently has a P/E ratio of 24.59, whereas IMAC's P/E ratio is -2.27. In terms of profitability, CON's ROE is +0.47%, compared to IMAC's ROE of +0.00%. Regarding short-term risk, CON is less volatile compared to IMAC. This indicates lower risk in terms of short-term price fluctuations for CON.Check IMAC's competition here
Cryo-Cell International, Inc. (AMEX: CCEL)
CON vs CCEL Comparison August 2026
Concentra Group Holdings Parent, Inc. (NYSE: CON) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CON stands at 4.5B. In comparison, CCEL has a market cap of 32.3M. Regarding current trading prices, CON is priced at $35.43 on the NYSE, while CCEL trades at $3.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CON currently has a P/E ratio of 24.59, whereas CCEL's P/E ratio is -13.33. In terms of profitability, CON's ROE is +0.47%, compared to CCEL's ROE of +0.14%. Regarding short-term risk, CON is less volatile compared to CCEL. This indicates lower risk in terms of short-term price fluctuations for CON.Check CCEL's competition here
EUDA Health Holdings Limited (NASDAQ: EUDA)
CON vs EUDA Comparison August 2026
Concentra Group Holdings Parent, Inc. (NYSE: CON) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CON stands at 4.5B. In comparison, EUDA has a market cap of 26.4M. Regarding current trading prices, CON is priced at $35.43 on the NYSE, while EUDA trades at $14.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CON currently has a P/E ratio of 24.59, whereas EUDA's P/E ratio is -26.63. In terms of profitability, CON's ROE is +0.47%, compared to EUDA's ROE of +1.20%. Regarding short-term risk, CON is less volatile compared to EUDA. This indicates lower risk in terms of short-term price fluctuations for CON.Check EUDA's competition here
Cano Health, Inc. (NYSE: CANO-WT)
CON vs CANO-WT Comparison August 2026
Concentra Group Holdings Parent, Inc. (NYSE: CON) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CON stands at 4.5B. In comparison, CANO-WT has a market cap of 19.3M. Regarding current trading prices, CON is priced at $35.43 on the NYSE, while CANO-WT trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CON currently has a P/E ratio of 24.59, whereas CANO-WT's P/E ratio is N/A. In terms of profitability, CON's ROE is +0.47%, compared to CANO-WT's ROE of -1.49%. Regarding short-term risk, CON is less volatile compared to CANO-WT. This indicates lower risk in terms of short-term price fluctuations for CON.Check CANO-WT's competition here
Aesthetic Medical International Holdings Group Limited (NASDAQ: AIH)
CON vs AIH Comparison August 2026
Concentra Group Holdings Parent, Inc. (NYSE: CON) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CON stands at 4.5B. In comparison, AIH has a market cap of 15.9M. Regarding current trading prices, CON is priced at $35.43 on the NYSE, while AIH trades at $0.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CON currently has a P/E ratio of 24.59, whereas AIH's P/E ratio is -2.78. In terms of profitability, CON's ROE is +0.47%, compared to AIH's ROE of +1.16%. Regarding short-term risk, CON is less volatile compared to AIH. This indicates lower risk in terms of short-term price fluctuations for CON.Check AIH's competition here
Cano Health, Inc. (NYSE: CANO)
CON vs CANO Comparison August 2026
Concentra Group Holdings Parent, Inc. (NYSE: CON) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CON stands at 4.5B. In comparison, CANO has a market cap of 12.4M. Regarding current trading prices, CON is priced at $35.43 on the NYSE, while CANO trades at $2.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CON currently has a P/E ratio of 24.59, whereas CANO's P/E ratio is -0.01. In terms of profitability, CON's ROE is +0.47%, compared to CANO's ROE of -1.49%. Regarding short-term risk, CON is less volatile compared to CANO. This indicates lower risk in terms of short-term price fluctuations for CON.Check CANO's competition here
Avem Health Partners, Inc. (NYSE: FPCG)
CON vs FPCG Comparison August 2026
Concentra Group Holdings Parent, Inc. (NYSE: CON) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CON stands at 4.5B. In comparison, FPCG has a market cap of 10.1M. Regarding current trading prices, CON is priced at $35.43 on the NYSE, while FPCG trades at $1,025.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CON currently has a P/E ratio of 24.59, whereas FPCG's P/E ratio is 0.09. In terms of profitability, CON's ROE is +0.47%, compared to FPCG's ROE of +0.00%. Regarding short-term risk, CON is more volatile compared to FPCG. This indicates higher risk in terms of short-term price fluctuations for CON.Check FPCG's competition here
American Shared Hospital Services (AMEX: AMS)
CON vs AMS Comparison August 2026
Concentra Group Holdings Parent, Inc. (NYSE: CON) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CON stands at 4.5B. In comparison, AMS has a market cap of 9.9M. Regarding current trading prices, CON is priced at $35.43 on the NYSE, while AMS trades at $1.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CON currently has a P/E ratio of 24.59, whereas AMS's P/E ratio is -6.74. In terms of profitability, CON's ROE is +0.47%, compared to AMS's ROE of -0.07%. Regarding short-term risk, CON is less volatile compared to AMS. This indicates lower risk in terms of short-term price fluctuations for CON.Check AMS's competition here
Field Trip Health Ltd. (NASDAQ: FTRP)
CON vs FTRP Comparison August 2026
Concentra Group Holdings Parent, Inc. (NYSE: CON) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CON stands at 4.5B. In comparison, FTRP has a market cap of 9.8M. Regarding current trading prices, CON is priced at $35.43 on the NYSE, while FTRP trades at $0.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CON currently has a P/E ratio of 24.59, whereas FTRP's P/E ratio is -1.22. In terms of profitability, CON's ROE is +0.47%, compared to FTRP's ROE of -0.62%. Regarding short-term risk, CON is less volatile compared to FTRP. This indicates lower risk in terms of short-term price fluctuations for CON.Check FTRP's competition here
Basel Medical Group Ltd Ordinary Shares (NASDAQ: BMGL)
CON vs BMGL Comparison August 2026
Concentra Group Holdings Parent, Inc. (NYSE: CON) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CON stands at 4.5B. In comparison, BMGL has a market cap of 8.6M. Regarding current trading prices, CON is priced at $35.43 on the NYSE, while BMGL trades at $5.26.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CON currently has a P/E ratio of 24.59, whereas BMGL's P/E ratio is -1.04. In terms of profitability, CON's ROE is +0.47%, compared to BMGL's ROE of -1.74%. Regarding short-term risk, CON is less volatile compared to BMGL. This indicates lower risk in terms of short-term price fluctuations for CON.Check BMGL's competition here
XWELL, Inc. (NASDAQ: XWEL)
CON vs XWEL Comparison August 2026
Concentra Group Holdings Parent, Inc. (NYSE: CON) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CON stands at 4.5B. In comparison, XWEL has a market cap of 7.9M. Regarding current trading prices, CON is priced at $35.43 on the NYSE, while XWEL trades at $0.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CON currently has a P/E ratio of 24.59, whereas XWEL's P/E ratio is -0.18. In terms of profitability, CON's ROE is +0.47%, compared to XWEL's ROE of +2.89%. Regarding short-term risk, CON is less volatile compared to XWEL. This indicates lower risk in terms of short-term price fluctuations for CON.Check XWEL's competition here
20/20 Biolabs Inc. (NASDAQ: AIDX)
CON vs AIDX Comparison August 2026
Concentra Group Holdings Parent, Inc. (NYSE: CON) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CON stands at 4.5B. In comparison, AIDX has a market cap of 6.7M. Regarding current trading prices, CON is priced at $35.43 on the NYSE, while AIDX trades at $0.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CON currently has a P/E ratio of 24.59, whereas AIDX's P/E ratio is -1.04. In terms of profitability, CON's ROE is +0.47%, compared to AIDX's ROE of +0.79%. Regarding short-term risk, CON is less volatile compared to AIDX. This indicates lower risk in terms of short-term price fluctuations for CON.Check AIDX's competition here
ModivCare Inc. (NASDAQ: MODV)
CON vs MODV Comparison August 2026
Concentra Group Holdings Parent, Inc. (NYSE: CON) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CON stands at 4.5B. In comparison, MODV has a market cap of 6.2M. Regarding current trading prices, CON is priced at $35.43 on the NYSE, while MODV trades at $0.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CON currently has a P/E ratio of 24.59, whereas MODV's P/E ratio is -0.06. In terms of profitability, CON's ROE is +0.47%, compared to MODV's ROE of +1.36%. Regarding short-term risk, CON is more volatile compared to MODV. This indicates higher risk in terms of short-term price fluctuations for CON.Check MODV's competition here
Greenbrook TMS Inc. (NASDAQ: GBNH)
CON vs GBNH Comparison August 2026
Concentra Group Holdings Parent, Inc. (NYSE: CON) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CON stands at 4.5B. In comparison, GBNH has a market cap of 5.5M. Regarding current trading prices, CON is priced at $35.43 on the NYSE, while GBNH trades at $0.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CON currently has a P/E ratio of 24.59, whereas GBNH's P/E ratio is -0.06. In terms of profitability, CON's ROE is +0.47%, compared to GBNH's ROE of +15.74%. Regarding short-term risk, CON is less volatile compared to GBNH. This indicates lower risk in terms of short-term price fluctuations for CON.Check GBNH's competition here
Regional Health Properties, Inc. (AMEX: RHE)
CON vs RHE Comparison August 2026
Concentra Group Holdings Parent, Inc. (NYSE: CON) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CON stands at 4.5B. In comparison, RHE has a market cap of 5.2M. Regarding current trading prices, CON is priced at $35.43 on the NYSE, while RHE trades at $2.77.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CON currently has a P/E ratio of 24.59, whereas RHE's P/E ratio is -1.79. In terms of profitability, CON's ROE is +0.47%, compared to RHE's ROE of -1.31%. Regarding short-term risk, CON is less volatile compared to RHE. This indicates lower risk in terms of short-term price fluctuations for CON.Check RHE's competition here
Regional Health Properties, Inc. (AMEX: RHE-PA)
CON vs RHE-PA Comparison August 2026
Concentra Group Holdings Parent, Inc. (NYSE: CON) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CON stands at 4.5B. In comparison, RHE-PA has a market cap of 5.2M. Regarding current trading prices, CON is priced at $35.43 on the NYSE, while RHE-PA trades at $0.68.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CON currently has a P/E ratio of 24.59, whereas RHE-PA's P/E ratio is -0.09. In terms of profitability, CON's ROE is +0.47%, compared to RHE-PA's ROE of +1.09%. Regarding short-term risk, CON is less volatile compared to RHE-PA. This indicates lower risk in terms of short-term price fluctuations for CON.Check RHE-PA's competition here
Oncology Institute, Inc. Warrant 2021-15.11.26 on Oncology Inst (NASDAQ: STLNW)
CON vs STLNW Comparison August 2026
Concentra Group Holdings Parent, Inc. (NYSE: CON) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CON stands at 4.5B. In comparison, STLNW has a market cap of 5M. Regarding current trading prices, CON is priced at $35.43 on the NYSE, while STLNW trades at $0.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CON currently has a P/E ratio of 24.59, whereas STLNW's P/E ratio is N/A. In terms of profitability, CON's ROE is +0.47%, compared to STLNW's ROE of N/A. Regarding short-term risk, CON is less volatile compared to STLNW. This indicates lower risk in terms of short-term price fluctuations for CON.Check STLNW's competition here
The Oncology Institute, Inc. (NASDAQ: TOIIW)
CON vs TOIIW Comparison August 2026
Concentra Group Holdings Parent, Inc. (NYSE: CON) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CON stands at 4.5B. In comparison, TOIIW has a market cap of 4.7M. Regarding current trading prices, CON is priced at $35.43 on the NYSE, while TOIIW trades at $0.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CON currently has a P/E ratio of 24.59, whereas TOIIW's P/E ratio is -0.17. In terms of profitability, CON's ROE is +0.47%, compared to TOIIW's ROE of +2.10%. Regarding short-term risk, CON is more volatile compared to TOIIW. This indicates higher risk in terms of short-term price fluctuations for CON.Check TOIIW's competition here
IMAC Holdings, Inc. (NASDAQ: IMACW)
CON vs IMACW Comparison August 2026
Concentra Group Holdings Parent, Inc. (NYSE: CON) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CON stands at 4.5B. In comparison, IMACW has a market cap of 1.7M. Regarding current trading prices, CON is priced at $35.43 on the NYSE, while IMACW trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CON currently has a P/E ratio of 24.59, whereas IMACW's P/E ratio is N/A. In terms of profitability, CON's ROE is +0.47%, compared to IMACW's ROE of +0.73%. Regarding short-term risk, CON is less volatile compared to IMACW. This indicates lower risk in terms of short-term price fluctuations for CON.Check IMACW's competition here
Nakamoto Inc. (NASDAQ: NAKAW)
CON vs NAKAW Comparison August 2026
Concentra Group Holdings Parent, Inc. (NYSE: CON) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CON stands at 4.5B. In comparison, NAKAW has a market cap of 1.5M. Regarding current trading prices, CON is priced at $35.43 on the NYSE, while NAKAW trades at $0.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CON currently has a P/E ratio of 24.59, whereas NAKAW's P/E ratio is -0.53. In terms of profitability, CON's ROE is +0.47%, compared to NAKAW's ROE of -1.05%. Regarding short-term risk, CON is more volatile compared to NAKAW. This indicates higher risk in terms of short-term price fluctuations for CON.Check NAKAW's competition here
Concord Medical Services Holdings Limited (NYSE: CCM)
CON vs CCM Comparison August 2026
Concentra Group Holdings Parent, Inc. (NYSE: CON) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CON stands at 4.5B. In comparison, CCM has a market cap of 690.2K. Regarding current trading prices, CON is priced at $35.43 on the NYSE, while CCM trades at $4.76.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CON currently has a P/E ratio of 24.59, whereas CCM's P/E ratio is -0.32. In terms of profitability, CON's ROE is +0.47%, compared to CCM's ROE of +0.06%. Regarding short-term risk, CON is less volatile compared to CCM. This indicates lower risk in terms of short-term price fluctuations for CON.Check CCM's competition here
NewGenIvf Group Limited (NASDAQ: NIVF)
CON vs NIVF Comparison August 2026
Concentra Group Holdings Parent, Inc. (NYSE: CON) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CON stands at 4.5B. In comparison, NIVF has a market cap of 109.4K. Regarding current trading prices, CON is priced at $35.43 on the NYSE, while NIVF trades at $0.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CON currently has a P/E ratio of 24.59, whereas NIVF's P/E ratio is 0.28. In terms of profitability, CON's ROE is +0.47%, compared to NIVF's ROE of +0.33%. Regarding short-term risk, CON is less volatile compared to NIVF. This indicates lower risk in terms of short-term price fluctuations for CON.Check NIVF's competition here
Mobile-health Network Solutions Class A Ordinary Shares (NASDAQ: MNDR)
CON vs MNDR Comparison August 2026
Concentra Group Holdings Parent, Inc. (NYSE: CON) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CON stands at 4.5B. In comparison, MNDR has a market cap of 42.3K. Regarding current trading prices, CON is priced at $35.43 on the NYSE, while MNDR trades at $1.73.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CON currently has a P/E ratio of 24.59, whereas MNDR's P/E ratio is -0.04. In terms of profitability, CON's ROE is +0.47%, compared to MNDR's ROE of -0.46%. Regarding short-term risk, CON is less volatile compared to MNDR. This indicates lower risk in terms of short-term price fluctuations for CON.Check MNDR's competition here
NewGenIvf Group Limited (NASDAQ: NIVFW)
CON vs NIVFW Comparison August 2026
Concentra Group Holdings Parent, Inc. (NYSE: CON) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CON stands at 4.5B. In comparison, NIVFW has a market cap of 39.8K. Regarding current trading prices, CON is priced at $35.43 on the NYSE, while NIVFW trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CON currently has a P/E ratio of 24.59, whereas NIVFW's P/E ratio is -0.01. In terms of profitability, CON's ROE is +0.47%, compared to NIVFW's ROE of +0.33%. Regarding short-term risk, CON is more volatile compared to NIVFW. This indicates higher risk in terms of short-term price fluctuations for CON.Check NIVFW's competition here
Talkspace, Inc. (NASDAQ: TALKW)
CON vs TALKW Comparison August 2026
Concentra Group Holdings Parent, Inc. (NYSE: CON) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CON stands at 4.5B. In comparison, TALKW has a market cap of 33.5K. Regarding current trading prices, CON is priced at $35.43 on the NYSE, while TALKW trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CON currently has a P/E ratio of 24.59, whereas TALKW's P/E ratio is 0.00. In terms of profitability, CON's ROE is +0.47%, compared to TALKW's ROE of +0.00%. Regarding short-term risk, CON is less volatile compared to TALKW. This indicates lower risk in terms of short-term price fluctuations for CON.Check TALKW's competition here
SOC Telemed, Inc. (NASDAQ: TLMD)
CON vs TLMD Comparison August 2026
Concentra Group Holdings Parent, Inc. (NYSE: CON) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CON stands at 4.5B. In comparison, TLMD has a market cap of 0. Regarding current trading prices, CON is priced at $35.43 on the NYSE, while TLMD trades at $3.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CON currently has a P/E ratio of 24.59, whereas TLMD's P/E ratio is -1.60. In terms of profitability, CON's ROE is +0.47%, compared to TLMD's ROE of -0.46%. Regarding short-term risk, CON is more volatile compared to TLMD. This indicates higher risk in terms of short-term price fluctuations for CON.Check TLMD's competition here
New Frontier Health Corporation (NYSE: NFH)
CON vs NFH Comparison August 2026
Concentra Group Holdings Parent, Inc. (NYSE: CON) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CON stands at 4.5B. In comparison, NFH has a market cap of 0. Regarding current trading prices, CON is priced at $35.43 on the NYSE, while NFH trades at $11.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CON currently has a P/E ratio of 24.59, whereas NFH's P/E ratio is -19.75. In terms of profitability, CON's ROE is +0.47%, compared to NFH's ROE of -0.06%. Regarding short-term risk, CON is more volatile compared to NFH. This indicates higher risk in terms of short-term price fluctuations for CON.Check NFH's competition here
DocGo Inc. (NASDAQ: DCGOW)
CON vs DCGOW Comparison August 2026
Concentra Group Holdings Parent, Inc. (NYSE: CON) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CON stands at 4.5B. In comparison, DCGOW has a market cap of 0. Regarding current trading prices, CON is priced at $35.43 on the NYSE, while DCGOW trades at $1.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CON currently has a P/E ratio of 24.59, whereas DCGOW's P/E ratio is N/A. In terms of profitability, CON's ROE is +0.47%, compared to DCGOW's ROE of -0.89%. Regarding short-term risk, CON is less volatile compared to DCGOW. This indicates lower risk in terms of short-term price fluctuations for CON.Check DCGOW's competition here
Diversicare Healthcare Services, Inc. (NASDAQ: DVCR)
CON vs DVCR Comparison August 2026
Concentra Group Holdings Parent, Inc. (NYSE: CON) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CON stands at 4.5B. In comparison, DVCR has a market cap of 0. Regarding current trading prices, CON is priced at $35.43 on the NYSE, while DVCR trades at $10.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CON currently has a P/E ratio of 24.59, whereas DVCR's P/E ratio is 28.34. In terms of profitability, CON's ROE is +0.47%, compared to DVCR's ROE of -0.15%. Regarding short-term risk, CON is more volatile compared to DVCR. This indicates higher risk in terms of short-term price fluctuations for CON.Check DVCR's competition here
Tivity Health, Inc. (NASDAQ: TVTY)
CON vs TVTY Comparison August 2026
Concentra Group Holdings Parent, Inc. (NYSE: CON) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CON stands at 4.5B. In comparison, TVTY has a market cap of 0. Regarding current trading prices, CON is priced at $35.43 on the NYSE, while TVTY trades at $32.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CON currently has a P/E ratio of 24.59, whereas TVTY's P/E ratio is 19.06. In terms of profitability, CON's ROE is +0.47%, compared to TVTY's ROE of +1.75%. Regarding short-term risk, CON is more volatile compared to TVTY. This indicates higher risk in terms of short-term price fluctuations for CON.Check TVTY's competition here
SOC Telemed, Inc. (NASDAQ: TLMDW)
CON vs TLMDW Comparison August 2026
Concentra Group Holdings Parent, Inc. (NYSE: CON) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CON stands at 4.5B. In comparison, TLMDW has a market cap of 0. Regarding current trading prices, CON is priced at $35.43 on the NYSE, while TLMDW trades at $0.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CON currently has a P/E ratio of 24.59, whereas TLMDW's P/E ratio is N/A. In terms of profitability, CON's ROE is +0.47%, compared to TLMDW's ROE of -0.46%. Regarding short-term risk, CON is less volatile compared to TLMDW. This indicates lower risk in terms of short-term price fluctuations for CON.Check TLMDW's competition here
Hanger, Inc. (NYSE: HNGR)
CON vs HNGR Comparison August 2026
Concentra Group Holdings Parent, Inc. (NYSE: CON) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CON stands at 4.5B. In comparison, HNGR has a market cap of 0. Regarding current trading prices, CON is priced at $35.43 on the NYSE, while HNGR trades at $18.72.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CON currently has a P/E ratio of 24.59, whereas HNGR's P/E ratio is 19.71. In terms of profitability, CON's ROE is +0.47%, compared to HNGR's ROE of +0.52%. Regarding short-term risk, CON is more volatile compared to HNGR. This indicates higher risk in terms of short-term price fluctuations for CON.Check HNGR's competition here
ATI Physical Therapy, Inc. (NYSE: ATIP-WT)
CON vs ATIP-WT Comparison August 2026
Concentra Group Holdings Parent, Inc. (NYSE: CON) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CON stands at 4.5B. In comparison, ATIP-WT has a market cap of 0. Regarding current trading prices, CON is priced at $35.43 on the NYSE, while ATIP-WT trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CON currently has a P/E ratio of 24.59, whereas ATIP-WT's P/E ratio is N/A. In terms of profitability, CON's ROE is +0.47%, compared to ATIP-WT's ROE of +2.05%. Regarding short-term risk, CON is less volatile compared to ATIP-WT. This indicates lower risk in terms of short-term price fluctuations for CON.Check ATIP-WT's competition here
Skylight Health Group Inc. (NASDAQ: SLHGP)
CON vs SLHGP Comparison August 2026
Concentra Group Holdings Parent, Inc. (NYSE: CON) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CON stands at 4.5B. In comparison, SLHGP has a market cap of 0. Regarding current trading prices, CON is priced at $35.43 on the NYSE, while SLHGP trades at $12.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CON currently has a P/E ratio of 24.59, whereas SLHGP's P/E ratio is -30.38. In terms of profitability, CON's ROE is +0.47%, compared to SLHGP's ROE of -0.48%. Regarding short-term risk, CON is more volatile compared to SLHGP. This indicates higher risk in terms of short-term price fluctuations for CON.Check SLHGP's competition here
Skylight Health Group Inc. (NASDAQ: SLHG)
CON vs SLHG Comparison August 2026
Concentra Group Holdings Parent, Inc. (NYSE: CON) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CON stands at 4.5B. In comparison, SLHG has a market cap of 0. Regarding current trading prices, CON is priced at $35.43 on the NYSE, while SLHG trades at $0.58.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CON currently has a P/E ratio of 24.59, whereas SLHG's P/E ratio is -1.48. In terms of profitability, CON's ROE is +0.47%, compared to SLHG's ROE of N/A. Regarding short-term risk, CON is less volatile compared to SLHG. This indicates lower risk in terms of short-term price fluctuations for CON.Check SLHG's competition here
Almost Family Inc. (NASDAQ: AFAM)
CON vs AFAM Comparison August 2026
Concentra Group Holdings Parent, Inc. (NYSE: CON) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CON stands at 4.5B. In comparison, AFAM has a market cap of 0. Regarding current trading prices, CON is priced at $35.43 on the NYSE, while AFAM trades at $56.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CON currently has a P/E ratio of 24.59, whereas AFAM's P/E ratio is N/A. In terms of profitability, CON's ROE is +0.47%, compared to AFAM's ROE of +0.06%. Regarding short-term risk, CON is less volatile compared to AFAM. This indicates lower risk in terms of short-term price fluctuations for CON.Check AFAM's competition here
Kindred Healthcare, Inc. (NYSE: KND)
CON vs KND Comparison August 2026
Concentra Group Holdings Parent, Inc. (NYSE: CON) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CON stands at 4.5B. In comparison, KND has a market cap of 0. Regarding current trading prices, CON is priced at $35.43 on the NYSE, while KND trades at $9.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CON currently has a P/E ratio of 24.59, whereas KND's P/E ratio is -1.14. In terms of profitability, CON's ROE is +0.47%, compared to KND's ROE of -0.53%. Regarding short-term risk, CON is more volatile compared to KND. This indicates higher risk in terms of short-term price fluctuations for CON.Check KND's competition here